Three-dimensional quantitative assessment of ablation margins based on registration of pre- and post-procedural MRI and distance map
- 246 Downloads
Contrast-enhanced MR images are widely used to confirm the adequacy of ablation margin after liver ablation for early prediction of local recurrence. However, quantitative assessment of the ablation margin by comparing pre- and post-procedural images remains challenging. We developed and tested a novel method for three-dimensional quantitative assessment of ablation margin based on non-rigid image registration and 3D distance map.
Our method was tested with pre- and post-procedural MR images acquired in 21 patients who underwent image-guided percutaneous liver ablation. The two images were co-registered using non-rigid intensity-based registration. After the tumor and ablation volumes were segmented, target volume coverage, percent of tumor coverage, and Dice similarity coefficient were calculated as metrics representing overall adequacy of ablation. In addition, 3D distance map around the tumor was computed and superimposed on the ablation volume to identify the area with insufficient margins. For patients with local recurrences, the follow-up images were registered to the post-procedural image. Three-dimensional minimum distance between the recurrence and the areas with insufficient margins was quantified.
The percent tumor coverage for all nonrecurrent cases was 100 %. Five cases had tumor recurrences, and the 3D distance map revealed insufficient tumor coverage or a 0-mm margin. It also showed that two recurrences were remote to the insufficient margin.
Non-rigid registration and 3D distance map allow us to quantitatively evaluate the adequacy of the ablation margin after percutaneous liver ablation. The method may be useful to predict local recurrences immediately following ablation procedure.
KeywordsLiver ablation MRI Image-guided intervention Ablation margin Image registration
The authors would like to thank Vincent M. Levesque for his assistance in collecting patient data.
Funding This study was supported by the National Institutes of Health (R01CA138586, R01EB020667, P41EB015898). S.Tani received funds from the Ministry of Education, Culture, Sports, Science, and Technology, Japan. The content of the material is solely the responsibility of the authors and does not necessarily represent the official views of these agencies.
Compliance with ethical standards
The study protocol has been reviewed and approved by the institutional review board at Brigham and Women’s Hospital (IRB# 2002P001166), and was HIPAA compliant. Informed consent was waived by our institutional review board. NH has a financial interest in Harmonus, a company developing image-guided therapy products. NH’s interests were reviewed and are managed by Brigham and Women’s Hospital and Partners HealthCare in accordance with their conflict of interest policies.
- 6.Claudon M, Dietrich CF, Choi BI, Cosgrove DO, Kudo M, Nolsøe CP, Piscaglia F, Wilson SR, Barr RG, Chammas MC, Chaubal NG, Chen MH, Clevert DA, Correas JM, Ding H, Forsberg F, Fowlkes JB, Gibson RN, Goldberg BB, Lassau N, Leen ELS, Mattrey RF, Moriyasu F, Solbiati L, Weskott HP, Xu HX (2013) Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver-update 2012. A WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultrasound Med Biol 39(2):187–210. doi: 10.1016/j.ultrasmedbio.2012.09.002 CrossRefPubMedGoogle Scholar
- 10.Elhawary H, Oguro S, Tuncali K, Morrison PR, Tatli S, Shyn PB, Silverman SG, Hata N (2010) Multimodality non-rigid image registration for planning, targeting and monitoring during CT-guided percutaneous liver tumor cryoablation. Acad Radiol 17(11):1334–1344. doi: 10.1016/j.acra.2010.06.004 CrossRefPubMedPubMedCentralGoogle Scholar
- 12.Fujioka C, Horiguchi J, Ishifuro M, Kakizawa H, Kiguchi M, Matsuura N, Hieda M, Tachikake T, Alam F, Furukawa T, Ito K (2006) A feasibility study: evaluation of radiofrequency ablation therapy to hepatocellular carcinoma using image registration of preoperative and postoperative CT. Acad Radiol 13(8):986–994. doi: 10.1016/j.acra.2006.05.011 CrossRefPubMedGoogle Scholar
- 13.Goldberg SN, Charboneau JW, Dodd GD, Dupuy DE, Gervais DA, Gillams AR, Kane RA, Lee FT, Livraghi T, McGahan JP, Rhim H, Silverman SG, Solbiati L, Vogl TJ, Wood BJ (2003) Image-guided tumor ablation: proposal for standardization of terms and reporting criteria1. Radiology 228(2):335–345. doi: 10.1148/radiol.2282021787 CrossRefPubMedGoogle Scholar
- 15.Hori T, Nagata K, Hasuike S, Onaga M, Motoda M, Moriuchi A, Iwakiri H, Uto H, Kato J, Ido A, Hayashi K, Tsubouchi H (2003) Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation. J Gastroenterol 38(10):977–981. doi: 10.1007/s00535-003-1181-0 CrossRefPubMedGoogle Scholar
- 16.Kettenbach J, Köstler W, Rücklinger E, Gustorff B, Hüpfl M, Wolf F, Peer K, Weigner M, Lammer J, Müller W, Goldberg SN (2003) Percutaneous saline-enhanced radiofrequency ablation of unresectable hepatic tumors: Initial experience in 26 patients. Am J Roentgenol 180(June):1537–1545. doi: 10.2214/ajr.180.6.1801537 CrossRefGoogle Scholar
- 18.Kim YS, Lee WJ, Rhim H, Lim HK, Choi D, Lee JY (2010) he minimal ablative margin of radiofrequency ablation of hepatocellular carcinoma greater than 2 and less than 5 cm needed to prevent local tumor progression: 3D quantitative assessment using CT image fusion. Am J Roentgenol 195:758–765. doi: 10.2214/AJR.09.2954
- 20.Koda M, Tokunaga S, Miyoshi K, Kishina M, Fujise Y, Kato J, Matono T, Okamoto K, Murawaki Y, Kakite S (2012) Assessment of ablative margin by unenhanced magnetic resonance imaging after radiofrequency ablation for hepatocellular carcinoma. Eur J Radiol 81(10):2730–2736. doi: 10.1016/j.ejrad.2011.11.013 CrossRefPubMedGoogle Scholar
- 21.Komorizono Y, Oketani M, Sako K, Yamasaki N, Shibatou T, Maeda M, Kohara K, Shigenobu S, Ishibashi K, Arima T (2003) Risk factors for local recurrence of small hepatocellular carcinoma tumors after a single session, single application of percutaneous radiofrequency ablation. Cancer 97(5):1253–1262. doi: 10.1002/cncr.11168 CrossRefPubMedGoogle Scholar
- 29.Mori K, Fukuda K, Asaoka H, Ueda T, Kunimatsu A, Okamoto Y, Nasu K, Fukunaga K, Morishita Y, Minami M (2009) Radiofrequency ablation of the liver: determination of ablative margin at MR imaging with impaired clearance of ferucarbotran-feasibility study. Radiology 251(2):557–565. doi: 10.1148/radiol.2512081161 CrossRefPubMedGoogle Scholar
- 32.Nakazawa T, Kokubu S, Shibuya A, Ono K, Watanabe M, Hidaka H, Tsuchihashi T, Saigenji K (2007) Radiofrequency ablation of hepatocellular carcinoma: correlation between local tumor progression after ablation and ablative margin. Am J Roentgenol 188(2):480–488. doi: 10.2214/AJR.05.2079 CrossRefGoogle Scholar
- 35.Niculescu G, Foran DJ, Nosher J (2007) Non-rigid registration of the liver in consecutive CT studies for assessment of tumor response to radiofrequency ablation. In: 29th annual international conference of the IEEE engineering in medicine and biology society, EMBS 2007, vol 2007, pp 856–859. doi: 10.1109/IEMBS.2007.4352425
- 36.Oguro S, Tokuda J, Elhawary H, Haker S, Kikinis R, Tempany CMC, Hata N (2009) MRI signal intensity based B-spline nonrigid registration for pre- and intraoperative imaging during prostate brachytherapy. J Magn Reson Imaging 30(5):1052–1058. doi: 10.1002/jmri.21955 CrossRefPubMedPubMedCentralGoogle Scholar
- 37.Oguro S, Tuncali K, Elhawary H, Morrison PR, Hata N, Silverman SG (2011) Image registration of pre-procedural MRI and intra-procedural CT images to aid CT-guided percutaneous cryoablation of renal tumors. Int J Comput Assist Radiol Surg 6(1):111–117. doi: 10.1007/s11548-010-0485-9 CrossRefPubMedPubMedCentralGoogle Scholar
- 42.Rozenblum N, Zeira E, Bulvik B, Gourevitch S, Yotvat H, Galun E, Goldberg SN (2015) Radiofrequency ablation: inflammatory changes in the periablative zone can induce global organ effects, including liver regeneration. Radiology 276(2):416–425. doi: 10.1148/radiol.15141918
- 47.Stewart BW, Wild CP (2014) World Cancer Report 2014. International Agency for Research on Cancer, WHO, GenevaGoogle Scholar
- 49.Tokuda J, Plishker W, Torabi M, Olubiyi OI, Zaki G, Tatli S, Silverman SG, Shekher R, Hata N (2015) Graphics processing unit accelerated nonrigid registration of MR images to CT images during CT-guided percutaneous liver tumor ablations. Acad Radiol 22(6):722–733. doi: 10.1016/j.acra.2015.01.007 CrossRefPubMedPubMedCentralGoogle Scholar